Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company Key Statistics
Pro Data ExportCurrent Valuation
| Market Cap | 55.84B |
| Enterprise Value | 58.95B |
| PE Ratio | 14.84 |
| PE 10 Pro | Go Pro |
| PEG Ratio | 0.9546 |
| Price / Sales Ratio | 2.599 |
| Price / Book Value | 3.437 |
| EV / Revenues Pro | Go Pro |
| EV / EBITDA Pro | Go Pro |
| EV / EBIT Pro | Go Pro |
| Operating Earnings Yield Pro | Go Pro |
Dividends and Shares
| Dividend | |
| Dividend Yield | 4.10% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | May 1, 2012 |
| Ex-Dividend Date | April 3, 2012 |
| Last Split Factor | 2.00 |
| Last Split Date | March 1, 1999 |
Profitability
| Gross Profit Margin | 75.19% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | 20.97% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 1.632 |
| Debt to Equity Ratio | 0.3333 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -0.69% |
| Year to Date Stock Returns | -6.10% |
| 1 Year Stock Returns | 16.23% |
| 3 Year Stock Returns | 69.52% |
| 52 Week High | 35.44 |
| 52 Week Low | 20.05 |
Income Statement
| Revenues TTM | 21.48B |
| Revenue Per Share TTM | 12.73 |
| Revenue Growth | 4.79% |
| Gross Profit TTM | 15.93B |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | 3.824B |
| Earnings Per Share TTM | 2.23 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -3.027B |
| Cash Financing TTM | -2.801B |
| Cash Operations TTM | 4.746B |
| Capital Expenditures | 123.00M |
Share Statistics
| Shares Outstanding | 1.688B |
Balance Sheet
| Cash and ST Investments | 5.029B |
| Total Assets | 32.41B |
| Liabilities | 16.16B |
| Book Value | 16.25B |
| Book Value per Share | 9.627 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 5.415B |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these BMY related companies
BMY News
Amylin (AMLN) Shares Jump as Bids Due Today, Sanofi (SNY), Merck (MRK) Said to Make First-Round Bids
May 25, 2:01PM Street Insider
May 25, 2:01PM Street Insider
@Urbane_Gorilla http://stks.co/3z5t $CYCC $CELG $BMY $REGN $PFE #ASCO12 checklist
about 3 days ago by biotech
about 3 days ago by biotech
RT @ianestepan $CLDX if this data was from $BMY,$ONXX,$MDVN,$DNA or $PFE - people would be soooooo excited....
about 4 days ago by N0M0NEY_N0H0NEY
about 4 days ago by N0M0NEY_N0H0NEY
News related to $BMY, currently +0.5% since open: 'Bristol-Myers says FDA clears Mass. plant' http://stks.co/3q1B
about 12 days ago by TradeBot
about 12 days ago by TradeBot
Six Suitors Join $BMY in Considering a Bid for $AMLN http://stks.co/3psG
about 12 days ago by abubnic
about 12 days ago by abubnic
The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL
about 12 days ago by abubnic
about 12 days ago by abubnic
Bristol-Myers (BMY) Announces FDA Approval of Devens, MA Plant for Manufacture of ORENCIA
May 15, 11:17AM Street Insider
May 15, 11:17AM Street Insider
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility
May 15, 11:01AM Benzinga
May 15, 11:01AM Benzinga
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept)
May 15, 11:00AM Business Wire
May 15, 11:00AM Business Wire
NR7 (EOD): Potential bullish NR7. Entry: 33.31. First Target: 34.00. $BMY http://chart.ly/qwxxeih
about 15 days ago by jackdamn
about 15 days ago by jackdamn
$BMY Ipilimumab,also known as MDX-010 or MDX-101 $DNDN Provenge along with $ARNA and $VVUS have been and are my Phamas for the next yr
about 16 days ago by selectstock
about 16 days ago by selectstock
Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference
May 10, 11:00AM Business Wire
May 10, 11:00AM Business Wire
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 20 days ago by abubnic
about 20 days ago by abubnic
Listen to $BMY Bristol-Myers Squibb at Deutsche Bank AG Health Care Conference - live at 10:40 AM, ondemand after - http://stks.co/3hTs
about 21 days ago by earningscast
about 21 days ago by earningscast
@russwm thanks working hard here. above 34 is a desc trend break + above 10day. needs to hold 50day $BMY http://chart.ly/mghypbo
about 26 days ago by TraderNewburgh
about 26 days ago by TraderNewburgh
@TraderNewburgh I would love to hear your thoughts on $BMY in the short/medium term, if you have the time. Love your videos.
about 26 days ago by russwm
about 26 days ago by russwm
Listen to $BMY Bristol-Myers Squibb Annual Meeting of Stockholders - live at 10:00 AM, ondemand after - http://stks.co/3bIu
about 27 days ago by earningscast
about 27 days ago by earningscast
http://stks.co/3XIO Health Care Report Take A Look $FURX $BMY $AMLN
about 31 days ago by Stockmarketman2
about 31 days ago by Stockmarketman2
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BMY | 33.09 | +0.10 | +0.30% | 55.84B |
| BMTI | 2.43 | +0.02 | +0.83% | 68.36M |
| BMRN | 38.64 | +0.13 | +0.34% | 4.468B |
| BMJ | 0.93 | +0.00 | +0.00% | |
| BMI | 36.69 | -0.25 | -0.68% | 550.35M |
| BMC | 43.69 | +0.72 | +1.68% | 7.175B |
| BMA | 13.46 | -0.33 | -2.39% | 785.12M |
| BLX | 19.14 | -0.08 | -0.42% | 540.90M |
| BLV | 93.83 | +0.41 | +0.44% | |
| BLTI | 2.42 | +0.06 | +2.54% | 74.27M |